Functional hydrogels as therapeutic tools for spinal cord injury: New perspectives on immunopharmacological interventions

• Published in: Pharmacology & therapeutics (Oxford) 2022-06, Vol.234, p.108043-108043, Article 108043
• Main Authors: Walsh, Ciara M., Wychowaniec, Jacek K., Brougham, Dermot F., Dooley, Dearbhaile
• Format: Article
• Language: English
• Subjects: Biocompatible Materials - therapeutic use; Controlled release; Drug delivery; Humans; Hydrogel; Hydrogels - therapeutic use; Immunomodulation; Nerve Regeneration; Neuroinflammation; Spinal Cord Injuries - drug therapy; Spinal cord injury
• ISSN: 0163-7258; 1879-016X
• DOI: 10.1016/j.pharmthera.2021.108043

Spinal cord injury (SCI) is a complex medical and psychological challenge for which there is no curative therapy currently available. Despite major progress in pharmacological and surgical approaches, clinical trials for SCI patients have been uniformly disappointing thus far as there are many practical and biological issues yet to be resolved. Neuroinflammation is a critical event of the secondary injury phase after SCI, and recent research strategies have focused on modulating the immune response after injury to provide a more favorable recovery environment. Biomaterials can serve this purpose by providing physical and trophic support to the injured spinal cord after SCI. Of all potential biomaterials, functional hydrogels are emerging as a key component in novel treatment strategies for SCI, including controlled and localized delivery of immunomodulatory therapies to drive polarization of immune cells towards a pro-regenerative phenotype. Here, we extensively review recent developments in the use of functional hydrogels as immunomodulatory therapies for SCI. We briefly describe physicochemical properties of hydrogels and demonstrate how advanced fabrication methods lead to the required heterogeneity and hierarchical arrangements that increasingly mimic complex spinal cord tissue. We then summarize potential SCI therapeutic modalities including: (i) hydrogels alone; (ii) hydrogels as cellular or (iii) bioactive molecule delivery vehicles, and; (iv) combinatorial approaches. By linking the structural properties of hydrogels to their functions in treatment with particular focus on immunopharmacological stimuli, this may accelerate further development of functional hydrogels for SCI, and indeed next-generation central nervous system regenerative therapies. [Display omitted]